Scarica l'app Stockscreener
7.32
5.48%
0.38
Dopo l'orario di chiusura:
7.22
-0.10
-1.37%
Precedente Chiudi:
$6.94
Aprire:
$7.45
Volume 24 ore:
264.53K
Relative Volume:
0.99
Capitalizzazione di mercato:
$160.02M
Reddito:
$52.55M
Utile/perdita netta:
$-23.69M
Rapporto P/E:
-7.7872
EPS:
-0.94
Flusso di cassa netto:
$-15.29M
1 W Prestazione:
+4.57%
1M Prestazione:
+5.02%
6M Prestazione:
+83.46%
1 anno Prestazione:
+267.84%
Intervallo 1D:
$7.32
$7.45
Intervallo di 1 settimana:
$6.7525
$7.45
Portata 52W:
$1.78
$7.95
Exagen Inc Stock (XGN) Company Profile
Nome
Exagen Inc
Settore
Industria
Telefono
(760) 560-1501
Indirizzo
1261 LIBERTY WAY, VISTA, CA
Confronta XGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
7.32 | 151.71M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
466.71 | 161.42B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.89 | 135.99B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
540.68 | 42.78B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.47 | 33.01B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
194.24 | 31.85B | 15.50B | 1.33B | 2.16B | 7.34 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-04-15 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-06-02 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Iniziato | Cowen | Outperform |
| 2019-10-14 | Iniziato | William Blair | Outperform |
Mostra tutto
Exagen Inc Borsa (XGN) Ultime notizie
Craig-Hallum initiates coverage on Exagen stock with Buy rating By Investing.com - Investing.com Canada
Craig-Hallum bullish on Exagen, initiates with a Buy - TipRanks
What analysts say about Exagen Inc. stockExponential return rates - Autocar Professional
Is Exagen Inc. a good long term investmentGame-changing capital returns - Autocar Professional
What drives Exagen Inc. stock priceFree Consultation - jammulinksnews.com
Exagen Inc. Stock Analysis and ForecastTremendous growth opportunities - jammulinksnews.com
Why Exagen Inc. stock attracts strong analyst attentionFree Stock Market Beginners Guide - Newser
What makes Exagen Inc. stock price move sharplyLong Term Safe Yield Focus - Newser
Exagen Appoints Chas McKhann to Board of Directors - The Globe and Mail
Exagen Inc. Appoints Chas McKhann to Board of Directors - AInvest
Exagen Inc. Appoints Chas McKhann to Board of Directors | XGN St - GuruFocus
Exagen appoints Chas McKhann to board of directors By Investing.com - Investing.com Nigeria
Exagen appoints Chas McKhann to board of directors - Investing.com Australia
Exagen Strengthens Board with Healthcare Veteran Behind Two Boston Scientific Acquisitions - Stock Titan
Michael Mahler Joins Exagen as Chief Scientific Officer - Medical Product Outsourcing
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire
How Exagen Inc. stock performs during market volatilityFree Risk Assessment Services - Newser
Exagen Inc. Announces Second Quarter 2025 Financial Results Release Date - AInvest
Exagen Inc. to Announce Q2 2025 Financial Results and Host Conference Call on July 29 - Nasdaq
Exagen Schedules Q2 2025 Earnings: CEO and CFO to Present Before Market Opens July 29 - Stock Titan
Exagen Inc.(NasdaqGM: XGN) added to Russell 3000E Index - MarketScreener
Exagen Inc.(NasdaqGM: XGN) added to Russell Microcap Growth Index - MarketScreener
Exagen Insider Ups Holding During Year - Yahoo.co
Exagen Inc. (XGN): Insider Confidence and Undervaluation Signal Buying Opportunity Ahead of Key Earnings - AInvest
Exagen announces resale of up to 1.15M shares - MSN
Exagen appoints Michael Mahler as CSO - TipRanks
Exagen appoints Dr. Michael Mahler as chief scientific officer - Investing.com
Analysts Issue Forecasts for Exagen FY2026 Earnings - Defense World
Millennium Management LLC Sells 6,649 Shares of Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Inc. Holds 2025 Annual Stockholder Meeting - TipRanks
Northern Trust Corp Has $75,000 Position in Exagen Inc. (NASDAQ:XGN) - Defense World
XGN Set to Participate in Virtual Meeting on June 11 | XGN Stock News - GuruFocus
Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World
Exagen stock soars to 52-week high, hits $7.2 amid robust gains By Investing.com - Investing.com South Africa
Exagen stock soars to 52-week high, hits $7.2 amid robust gains - Investing.com Nigeria
Exagen Inc Azioni (XGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.84%
1.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):